Lyell Immunopharma, Inc. (LYEL) Earnings
NASDAQ·Healthcare·Biotechnology
$13.45
-2.00%
Mkt Cap $279.31M
EPS — Estimate vs Actual
Mkt Cap
$279.31M
P/E
—
Fwd P/E
—
P/S
9009.97
Rev TTM
—
EPS TTM
-$12.74
NASDAQ·Healthcare·Biotechnology
$13.45
-2.00%
Mkt Cap $279.31M
Mkt Cap
$279.31M
P/E
—
Fwd P/E
—
P/S
9009.97
Rev TTM
—
EPS TTM
-$12.74